KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia

Introduction. Mast cell (MC) leukemia (MCL) is extremely rare. We present a case of MCL diagnosed concomitantly with acute myeloblastic leukemia (AML). Case Report. A 41-year-old woman presented with asthenia, anorexia, fever, epigastralgia, and diarrhea. She had a maculopapular skin rash, hepatospl...

Full description

Saved in:
Bibliographic Details
Main Authors: Marta Lopes, Maria dos Anjos Teixeira, Cláudia Casais, Vanessa Mesquita, Patrícia Seabra, Renata Cabral, José Palla-García, Catarina Lau, João Rodrigues, Maria Jara-Acevedo, Inês Freitas, Jose Ramón Vizcaíno, Jorge Coutinho, Luis Escribano, Alberto Orfao, Margarida Lima
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2018/3890361
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562111035736064
author Marta Lopes
Maria dos Anjos Teixeira
Cláudia Casais
Vanessa Mesquita
Patrícia Seabra
Renata Cabral
José Palla-García
Catarina Lau
João Rodrigues
Maria Jara-Acevedo
Inês Freitas
Jose Ramón Vizcaíno
Jorge Coutinho
Luis Escribano
Alberto Orfao
Margarida Lima
author_facet Marta Lopes
Maria dos Anjos Teixeira
Cláudia Casais
Vanessa Mesquita
Patrícia Seabra
Renata Cabral
José Palla-García
Catarina Lau
João Rodrigues
Maria Jara-Acevedo
Inês Freitas
Jose Ramón Vizcaíno
Jorge Coutinho
Luis Escribano
Alberto Orfao
Margarida Lima
author_sort Marta Lopes
collection DOAJ
description Introduction. Mast cell (MC) leukemia (MCL) is extremely rare. We present a case of MCL diagnosed concomitantly with acute myeloblastic leukemia (AML). Case Report. A 41-year-old woman presented with asthenia, anorexia, fever, epigastralgia, and diarrhea. She had a maculopapular skin rash, hepatosplenomegaly, retroperitoneal adenopathies, pancytopenia, 6% blast cells (BC) and 20% MC in the peripheral blood, elevated lactate dehydrogenase, cholestasis, hypoalbuminemia, hypogammaglobulinemia, and increased serum tryptase (184 μg/L). The bone marrow (BM) smears showed 24% myeloblasts, 17% promyelocytes, and 16% abnormal toluidine blue positive MC, and flow cytometry revealed 12% myeloid BC, 34% aberrant promyelocytes, a maturation blockage at the myeloblast/promyelocyte level, and 16% abnormal CD2−CD25+ MC. The BM karyotype was normal, and the KIT D816V mutation was positive in BM cells. The diagnosis of MCL associated with AML was assumed. The patient received corticosteroids, disodium cromoglycate, cladribine, idarubicin and cytosine arabinoside, high-dose cytosine arabinoside, and hematopoietic stem cell transplantation (HSCT). The outcome was favorable, with complete hematological remission two years after diagnosis and one year after HSCT. Conclusions. This case emphasizes the need of an exhaustive laboratory evaluation for the concomitant diagnosis of MCL and AML, and the therapeutic options.
format Article
id doaj-art-5a2f510b8b2e42de8f80aa617deb848f
institution Kabale University
issn 2090-6560
2090-6579
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-5a2f510b8b2e42de8f80aa617deb848f2025-02-03T01:23:24ZengWileyCase Reports in Hematology2090-65602090-65792018-01-01201810.1155/2018/38903613890361KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid LeukemiaMarta Lopes0Maria dos Anjos Teixeira1Cláudia Casais2Vanessa Mesquita3Patrícia Seabra4Renata Cabral5José Palla-García6Catarina Lau7João Rodrigues8Maria Jara-Acevedo9Inês Freitas10Jose Ramón Vizcaíno11Jorge Coutinho12Luis Escribano13Alberto Orfao14Margarida Lima15Serviço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalServiço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalServiço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalServiço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalServiço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalServiço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalServiço de Anatomia Patológica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalServiço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalServiço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalSequencing Service (NUCLEUS), University of Salamanca, Salamanca, SpainUnidade Multidisciplinar de Investigação Biomédicas, Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto (UMIB/ICBAS/UP), Porto, PortugalServiço de Anatomia Patológica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalServiço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, SpainInstitute of Biomedical Research of Salamanca (IBSAL), Salamanca, SpainServiço de Hematologia Clínica, Hospital de Santo António (HSA), Centro Hospitalar do Porto (CHP), Porto, PortugalIntroduction. Mast cell (MC) leukemia (MCL) is extremely rare. We present a case of MCL diagnosed concomitantly with acute myeloblastic leukemia (AML). Case Report. A 41-year-old woman presented with asthenia, anorexia, fever, epigastralgia, and diarrhea. She had a maculopapular skin rash, hepatosplenomegaly, retroperitoneal adenopathies, pancytopenia, 6% blast cells (BC) and 20% MC in the peripheral blood, elevated lactate dehydrogenase, cholestasis, hypoalbuminemia, hypogammaglobulinemia, and increased serum tryptase (184 μg/L). The bone marrow (BM) smears showed 24% myeloblasts, 17% promyelocytes, and 16% abnormal toluidine blue positive MC, and flow cytometry revealed 12% myeloid BC, 34% aberrant promyelocytes, a maturation blockage at the myeloblast/promyelocyte level, and 16% abnormal CD2−CD25+ MC. The BM karyotype was normal, and the KIT D816V mutation was positive in BM cells. The diagnosis of MCL associated with AML was assumed. The patient received corticosteroids, disodium cromoglycate, cladribine, idarubicin and cytosine arabinoside, high-dose cytosine arabinoside, and hematopoietic stem cell transplantation (HSCT). The outcome was favorable, with complete hematological remission two years after diagnosis and one year after HSCT. Conclusions. This case emphasizes the need of an exhaustive laboratory evaluation for the concomitant diagnosis of MCL and AML, and the therapeutic options.http://dx.doi.org/10.1155/2018/3890361
spellingShingle Marta Lopes
Maria dos Anjos Teixeira
Cláudia Casais
Vanessa Mesquita
Patrícia Seabra
Renata Cabral
José Palla-García
Catarina Lau
João Rodrigues
Maria Jara-Acevedo
Inês Freitas
Jose Ramón Vizcaíno
Jorge Coutinho
Luis Escribano
Alberto Orfao
Margarida Lima
KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia
Case Reports in Hematology
title KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia
title_full KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia
title_fullStr KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia
title_full_unstemmed KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia
title_short KIT D816V Positive Acute Mast Cell Leukemia Associated with Normal Karyotype Acute Myeloid Leukemia
title_sort kit d816v positive acute mast cell leukemia associated with normal karyotype acute myeloid leukemia
url http://dx.doi.org/10.1155/2018/3890361
work_keys_str_mv AT martalopes kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT mariadosanjosteixeira kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT claudiacasais kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT vanessamesquita kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT patriciaseabra kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT renatacabral kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT josepallagarcia kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT catarinalau kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT joaorodrigues kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT mariajaraacevedo kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT inesfreitas kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT joseramonvizcaino kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT jorgecoutinho kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT luisescribano kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT albertoorfao kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia
AT margaridalima kitd816vpositiveacutemastcellleukemiaassociatedwithnormalkaryotypeacutemyeloidleukemia